Two years survival of primary cardiac leiomyosarcoma managed by surgical and adjuvant therapy

BACKGROUND: Cardiac tumors are a very rare entity. Leiomyosarcoma represents less than 1% of cases. CASE PRESENTATION: a 51-year-old woman diagnosed with primary left atrium leiomyosarcoma. She was treated by optimal surgery and adjuvant chemotherapy. She is still alive after a follow-up of 24 month...

Descripción completa

Detalles Bibliográficos
Autores principales: Behi, K., Ayadi, M., Mezni, E., Meddeb, K., Mokrani, A., Yahyaoui, Y., Ksontini, F., Rais, H., Chrait, N., Mezlini, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5343408/
https://www.ncbi.nlm.nih.gov/pubmed/28286642
http://dx.doi.org/10.1186/s13569-017-0069-3
_version_ 1782513358188052480
author Behi, K.
Ayadi, M.
Mezni, E.
Meddeb, K.
Mokrani, A.
Yahyaoui, Y.
Ksontini, F.
Rais, H.
Chrait, N.
Mezlini, A.
author_facet Behi, K.
Ayadi, M.
Mezni, E.
Meddeb, K.
Mokrani, A.
Yahyaoui, Y.
Ksontini, F.
Rais, H.
Chrait, N.
Mezlini, A.
author_sort Behi, K.
collection PubMed
description BACKGROUND: Cardiac tumors are a very rare entity. Leiomyosarcoma represents less than 1% of cases. CASE PRESENTATION: a 51-year-old woman diagnosed with primary left atrium leiomyosarcoma. She was treated by optimal surgery and adjuvant chemotherapy. She is still alive after a follow-up of 24 months without evidence of local or distant recurrence. CONCLUSIONS: Cardiac leiomyosarcoma is a rare tumor with a dismal prognosis. Surgery is the mainstay of treatment. Adjuvant treatment is still controversial.
format Online
Article
Text
id pubmed-5343408
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-53434082017-03-10 Two years survival of primary cardiac leiomyosarcoma managed by surgical and adjuvant therapy Behi, K. Ayadi, M. Mezni, E. Meddeb, K. Mokrani, A. Yahyaoui, Y. Ksontini, F. Rais, H. Chrait, N. Mezlini, A. Clin Sarcoma Res Case Report BACKGROUND: Cardiac tumors are a very rare entity. Leiomyosarcoma represents less than 1% of cases. CASE PRESENTATION: a 51-year-old woman diagnosed with primary left atrium leiomyosarcoma. She was treated by optimal surgery and adjuvant chemotherapy. She is still alive after a follow-up of 24 months without evidence of local or distant recurrence. CONCLUSIONS: Cardiac leiomyosarcoma is a rare tumor with a dismal prognosis. Surgery is the mainstay of treatment. Adjuvant treatment is still controversial. BioMed Central 2017-03-09 /pmc/articles/PMC5343408/ /pubmed/28286642 http://dx.doi.org/10.1186/s13569-017-0069-3 Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Case Report
Behi, K.
Ayadi, M.
Mezni, E.
Meddeb, K.
Mokrani, A.
Yahyaoui, Y.
Ksontini, F.
Rais, H.
Chrait, N.
Mezlini, A.
Two years survival of primary cardiac leiomyosarcoma managed by surgical and adjuvant therapy
title Two years survival of primary cardiac leiomyosarcoma managed by surgical and adjuvant therapy
title_full Two years survival of primary cardiac leiomyosarcoma managed by surgical and adjuvant therapy
title_fullStr Two years survival of primary cardiac leiomyosarcoma managed by surgical and adjuvant therapy
title_full_unstemmed Two years survival of primary cardiac leiomyosarcoma managed by surgical and adjuvant therapy
title_short Two years survival of primary cardiac leiomyosarcoma managed by surgical and adjuvant therapy
title_sort two years survival of primary cardiac leiomyosarcoma managed by surgical and adjuvant therapy
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5343408/
https://www.ncbi.nlm.nih.gov/pubmed/28286642
http://dx.doi.org/10.1186/s13569-017-0069-3
work_keys_str_mv AT behik twoyearssurvivalofprimarycardiacleiomyosarcomamanagedbysurgicalandadjuvanttherapy
AT ayadim twoyearssurvivalofprimarycardiacleiomyosarcomamanagedbysurgicalandadjuvanttherapy
AT meznie twoyearssurvivalofprimarycardiacleiomyosarcomamanagedbysurgicalandadjuvanttherapy
AT meddebk twoyearssurvivalofprimarycardiacleiomyosarcomamanagedbysurgicalandadjuvanttherapy
AT mokrania twoyearssurvivalofprimarycardiacleiomyosarcomamanagedbysurgicalandadjuvanttherapy
AT yahyaouiy twoyearssurvivalofprimarycardiacleiomyosarcomamanagedbysurgicalandadjuvanttherapy
AT ksontinif twoyearssurvivalofprimarycardiacleiomyosarcomamanagedbysurgicalandadjuvanttherapy
AT raish twoyearssurvivalofprimarycardiacleiomyosarcomamanagedbysurgicalandadjuvanttherapy
AT chraitn twoyearssurvivalofprimarycardiacleiomyosarcomamanagedbysurgicalandadjuvanttherapy
AT mezlinia twoyearssurvivalofprimarycardiacleiomyosarcomamanagedbysurgicalandadjuvanttherapy

Ejemplares similares